Vascular embolization, also known as embolotherapy, is a medical procedure that involves the use of embolic agents to block or occlude blood vessels. Embolic agents can be solid particles, liquid substances, or devices that are introduced into the bloodstream through a catheter and directed to the site of the target vessel.
The embolic agents can be used to treat a variety of medical conditions, including:
Tumors: Embolization can be used to treat tumors by cutting off the blood supply to the tumor, which can shrink or kill the tumor. This technique is commonly used for liver, kidney, and lung tumors.
Request sample - https://www.alliedmarketresearch.com/request-sample/13615
Aneurysms: Embolization can be used to treat aneurysms by blocking the blood flow to the weakened area of the blood vessel. This can prevent the aneurysm from rupturing.
Arteriovenous malformations (AVMs): Embolization can be used to treat AVMs by blocking the abnormal connections between arteries and veins. This can reduce the risk of bleeding and other complications.
Bleeding: Embolization can be used to stop bleeding by blocking the blood vessel that is causing the bleeding. This technique is commonly used for gastrointestinal bleeding, uterine bleeding, and traumatic bleeding.
The embolization procedure is usually performed by an interventional radiologist or an interventional neuroradiologist. It is typically done under local anesthesia, and patients may be given sedation or general anesthesia if necessary. After the procedure, patients are usually monitored for several hours to ensure that there are no complications. Most patients can return home the same day or the following day.
Procure Complete Report (282 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/c6eb6ab41eb3b6d5de93673c1e715038
Based on application, the neurology segment contributed to nearly half of the global market revenue in 2021, and is expected to dominate by 2031. At the same time, the oncology segment would showcase the fastest CAGR of 8.3% throughout the forecast period. The other segments assessed through the study include peripheral vascular diseases and urology & nephrology.
By end-user, the hospitals and clinics segment garnered the highest share in 2021, generating nearly two-thirds of the global market. The same segment would also project the fastest CAGR of 8.1% from 2022 to 2031. The ambulatory surgical centers segment is also studied through the report.
Based on region, the market across North America generated nearly two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would manifest the fastest CAGR of 9.2% during the forecast period. The other regions studied in the report include Europe and LAMEA.
Key Players -
- BOSTON SCIENTIFIC CORPORATION,
- MERIT MEDICAL SYSTEMS,
- TERUMO CORPORATION,
- MEDTRONIC PLC,
- ABBOTT LABORATORIES,
- DEPUY SYNTHES (J&J MEDICAL DEVICES),
- COOK MEDICAL,
- BALT,
- KANEKA CORPORATION,
- and STRYKER CORPORATION
